ERBB2 and breast carcinoma: To the best of the authors’ knowledge, this study enrolled the largest number of breast cancer patients with paired CNB and FSS samples to evaluate ER, PR, HER2, and Ki67 status, finding that invasive BC patients with discordance HR status had similar tumor characteristics, adjuvant chemotherapy usage, and disease outcome compared with patients with both HR negative tumors.